News &amp; Updates

Around 40 percent of children who have undergone a surgical procedure for complicated appendicitis can be safely sent home for recovery, as shown in a pilot study.

Home recovery after surgery for complicated appendicitis feasible for some children

Original New Drug Application Approvals by US FDA (1-15 March 2025)

New drug applications approved by US FDA as of 1-15 March 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 March 2025)

Sports-related concussion not a culprit of long-term cognitive or behavioural deficit

04 Apr 2025 by

Individuals with sports-related concussion (SRC) in the general population showed no long-term cognitive or behavioural deficits compared with those have not had concussion, a study has found.

Sports-related concussion not a culprit of long-term cognitive or behavioural deficit

Is vitiligo as side effect a good sign for cancer patients on immunotherapy?

Vitiligo occurs as a cutaneous immune-related adverse event during immune checkpoint inhibitor (ICI) therapy in most melanoma and nonmelanoma cancer patients with partial or complete response to treatment, according to a systematic review.

Is vitiligo as side effect a good sign for cancer patients on immunotherapy?

03 Apr 2025

25M people seen to live with Parkinson’s disease in 2050

At least 25 million individuals around the world are expected to live with Parkinson’s disease (PD) by the year 2050, posing a substantial public health challenge not just for patients and their families, but for caregivers, communities, and society as well, according to a study.

25M people seen to live with Parkinson’s disease in 2050

03 Apr 2025

Ganciclovir/valganciclovir tied to adverse effects in preterm infants with CMV

Preterm and very low birthweight (VLBW) infants who have been treated with ganciclovir (GCV) or oral valganciclovir (valGCV) for cytomegalovirus (CMV) disease are more likely to experience adverse events than term infants, a study has shown.

Ganciclovir/valganciclovir tied to adverse effects in preterm infants with CMV

EGFR gene mutation abundance predicts survival in NSCLC patients

In patients with nonsmall cell lung cancer (NSCLC), plasma epidermal growth factor receptor (EGFR) mutation abundance shows a significant association with survival benefit, reveals a study.

EGFR gene mutation abundance predicts survival in NSCLC patients

Delayed motherhood poses thyroid cancer risk

Women who gave birth to their first child at an older age face an increased risk of thyroid cancer development, according to an analysis of Asian cohort studies.

Delayed motherhood poses thyroid cancer risk

Penicillin allergy delabelled in 90 percent of patients after evaluation

Research from Queen Mary Hospital in Hong Kong shows that 90 percent of patients with suspected penicillin allergy were delabelled after undergoing Prospective Assessment of Penicillin Allergy (PAPA), and one in six of them received penicillins safely ≥6 months later.

Penicillin allergy delabelled in 90 percent of patients after evaluation

Zero HIV acquisition, high persistence through 1 year with cabotegravir LA as PrEP for MSM, transgender men

“Zero HIV acquisition” is a milestone that cabotegravir LA as PrEP has realized in the PILLAR real-world trial, along with high persistence observed through 12 months among 201 MSM and transgender men

Zero HIV acquisition, high persistence through 1 year with cabotegravir LA as PrEP for MSM, transgender men